Clinical Trials

Hydroxychloroquine Linked to Nearly 17,000 Deaths During First COVID-19 Wave

The anti-malaria drug, promoted as a potential COVID-19 treatment, was associated with an increased mortality rate, primarily due to cardiac complications.